PGR and breast cancer: The majority of BC expresses established clinical biomarkers, such as the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki67 [12], which are used to guide treatment decisions and serve as surrogates for prognosis.